Carlsmed Unveils Aprevo® Technology for Cervical Fusion
Carlsmed, Inc. (Nasdaq: CARL) has officially launched its innovative aprevo® Technology Platform, designed specifically for cervical fusion surgeries. This exciting development represents a significant leap forward in the field of spine surgery, ensuring a more personalized approach tailored to each patient's unique anatomical needs.
Enhancing Surgical Outcomes with Personalization
The aprevo® Cervical Interbody System is an extension of Carlsmed's personalized spine platform, which marries artificial intelligence with advanced manufacturing practices. This technology allows for the creation of 3D-printed, patient-specific implants. These are designed based on comprehensive preoperative assessments, leading to improved fit and alignment during surgeries.
Building on Past Successes
This cervical system builds upon the impressive track record of the aprevo® lumbar platform, which has successfully demonstrated a reduction in complications and the need for revision surgeries when compared to traditional stock implants.
Meeting Growing Surgical Demand
In recent figures, over 370,000 cervical fusion procedures were conducted within the U.S. alone, highlighting a growing demand for enhanced surgical technologies. Increasingly, surgeons seek solutions that improve patient outcomes, particularly for individuals with compromised bone quality.
Clinician Insights and Early Data
During the Cervical Spine Research Society (CSRS) meeting, early clinical data on the efficacy of the aprevo® platform will be shared by participating surgeons. These experienced professionals have acknowledged significant benefits, including efficient workflow integration and precision in implant placement, which ultimately contributes to maximizing patient recovery.
Expert Opinions on Personalization
Dr. Andrew Chan, MD, from Columbia University / New York-Presbyterian Och Spine Hospital, attests to the potential of this technology. He notes, "The ability to deliver a perfectly matched device tailored to a patient's unique anatomy greatly enhances our capacity to correct alignment and custom-fit solutions for more complex cases."
Workshop for Surgeons at CSRS
Carlsmed will host a workshop at the CSRS meeting on upcoming advancements in cervical surgery techniques.
Workshop Details:
Date: Thursday, December 4, 2025
Time: 12:30-1:30 PM EST
Location: Meeting Room 8 - Meeting Level
Featured Speakers: Dr. Andrew Chan, Dr. Deb Bhowmick from Duke University, and Dr. Venu Nemani from Virginia Mason Medical Center.
About Carlsmed
Carlsmed is driven by a mission to revolutionize spine surgery through AI-enabled solutions. Their focus is on optimizing surgical outcomes while reducing overall healthcare costs associated with spine procedures.
Frequently Asked Questions
What is the aprevo® Technology Platform?
The aprevo® Technology Platform is a personalized solution for cervical fusion surgeries, utilizing AI and 3D printing to create patient-specific implants.
How does the aprevo® technology improve surgical outcomes?
This technology allows for precise preoperative planning and delivery of customized implants that conform well to each patient's unique anatomy.
What feedback has been received from surgeons?
Surgeons have reported positive clinical outcomes, including fewer complications and better alignment in early evaluations.
When and where was the aprevo® technology launched?
The U.S. commercial launch of the aprevo® Technology Platform was announced recently at the Cervical Spine Research Society meeting.
What is Carlsmed's goal with this technology?
Carlsmed aims to transform the standard of care in spine surgeries by enhancing personalization and improving patient outcomes in cervical procedures.
